Regulatory approval & commercialization of an RBC processing and storage system to improve transfusion therapy by minimizing oxidative damage to RBC…
Ended Project Grant Awarded Last action
- Award ID
- R44HL132172
- Recipient
-
New Health Sciences, Inc. UEI CC3QRDB7EYX7
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,969,756
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Originally
- Place of performance
- Massachusetts, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $1 | |
| Amendment | $1 | |
| Amendment | -$1 | |
| Amendment | -$1 | |
| Amendment | -$1 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $980,623 | |
| Amendment | $997,658 | |
| Original award | $991,476 |
Show all 12
Quick answers
Who received award R44HL132172?
R44HL132172 was awarded to New Health Sciences, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on August 15, 2016.
How much is award R44HL132172 worth?
$2,969,756 has been obligated on R44HL132172.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award